# Baxter Healthcare Corporation - Inspection Records

Source: https://www.keypedia.com/companies/baxter-healthcare-corporation/423140fe-c265-4bca-a8da-34ee943c5378

> Inspection records and compliance data for Baxter Healthcare Corporation in Marion, NC. Access full analysis and detailed observations.

---

## Details

- Name: Baxter Healthcare Corporation
- City: Marion
- State: NC
- Country Name: Canada
- Address Line 1: 65 Pitts Station Road, Highway 221 North (North Cove)
- Zip Code: 28752-1390

## Related Documents

- [Canada Inspection - Baxter Healthcare Corporation - Inspection #87016 - 2025-09-15](https://www.keypedia.com/records/canada_inspection/baxter-healthcare-corporation/112d3fe1-23de-4fe2-a153-3045fd30e52d) — source: Canada, date: September 15, 2025
- [Canada Inspection - Baxter Healthcare Corporation - Inspection #87162 - 2025-06-02](https://www.keypedia.com/records/canada_inspection/baxter-healthcare-corporation/65aa5b42-0501-470b-a80f-0788ecd29d83) — source: Canada, date: June 2, 2025
- [Canada Inspection - Baxter Healthcare Corporation - Inspection #86500 - 2024-07-23](https://www.keypedia.com/records/canada_inspection/baxter-healthcare-corporation/b910e077-71db-4742-95ad-26e08dbab85d) — source: Canada, date: July 23, 2024
- [Canada Inspection - Baxter Healthcare Corporation - Inspection #86799 - 2024-07-08](https://www.keypedia.com/records/canada_inspection/baxter-healthcare-corporation/5f03da5a-e846-4bb2-90ef-fd2a9de70139) — source: Canada, date: July 8, 2024
- [Canada Inspection - Baxter Healthcare Corporation - Inspection #85903 - 2023-12-04](https://www.keypedia.com/records/canada_inspection/baxter-healthcare-corporation/92cdf2ee-6603-4a8c-aa90-d6f1ce0aba3c) — source: Canada, date: December 4, 2023
- [Canada Inspection - Baxter Healthcare Corporation - Inspection #78163 - 2021-07-19](https://www.keypedia.com/records/canada_inspection/baxter-healthcare-corporation/21a659cc-8991-49e2-b56e-4c19c7e6b448) — source: Canada, date: July 19, 2021
- [Canada Inspection - Baxter Healthcare Corporation - Inspection #78362 - 2021-06-23](https://www.keypedia.com/records/canada_inspection/baxter-healthcare-corporation/3a1fb730-5c45-4457-87d9-c2ba1db8b719) — source: Canada, date: June 23, 2021
- [Canada Inspection - Baxter Healthcare Corporation - Inspection #80064 - 2020-09-09](https://www.keypedia.com/records/canada_inspection/baxter-healthcare-corporation/3cead80b-acb7-494e-80b3-2c2cdea261cc) — source: Canada, date: September 9, 2020
- [Canada Inspection - Baxter Healthcare Corporation - Inspection #72580 - 2019-10-21](https://www.keypedia.com/records/canada_inspection/baxter-healthcare-corporation/8d646aef-c06a-4ee4-a666-abc2545ed998) — source: Canada, date: October 21, 2019
- [Canada Inspection - Baxter Healthcare Corporation - Inspection #72134 - 2018-12-03](https://www.keypedia.com/records/canada_inspection/baxter-healthcare-corporation/574012e4-0eab-4851-8da0-0f6cb8082e4c) — source: Canada, date: December 3, 2018

## Related Companies

- [AstraZeneca AB](https://www.keypedia.com/companies/astrazeneca-ab/a70f18df-57e0-4a18-b898-e51d76a67f37)
- [Novo Nordisk A/S](https://www.keypedia.com/companies/novo-nordisk-as/2522e48f-143e-4ae8-9b09-9d2f60c84321)
- [ACS Dobfar S.P.A.](https://www.keypedia.com/companies/acs-dobfar-spa/47f2473f-1510-4e5e-b84b-0f0f41c7a820)
- [Olon S.p.A.](https://www.keypedia.com/companies/olon-spa/9b536927-3235-4b50-88e1-9252a76e9d19)
- [Sanofi Chimie](https://www.keypedia.com/companies/sanofi-chimie/a6a658f3-1386-4dcf-baf7-2b568996f298)
- [Lek Pharmaceuticals d.d.](https://www.keypedia.com/companies/lek-pharmaceuticals-dd/6270f98c-f7d4-4ab2-b047-247854fc55f4)
- [Incepta Pharmaceuticals Limited](https://www.keypedia.com/companies/incepta-pharmaceuticals-limited/531407dc-a2c8-42a5-9394-751d1e4cf5de)
- [Celltrion Pharm Inc](https://www.keypedia.com/companies/celltrion-pharm-inc/56dd83f1-7490-44fd-a3ae-612f362f9c2a)
- [Fresenius Kabi USA LLC](https://www.keypedia.com/companies/fresenius-kabi-usa-llc/7548720b-e1a5-47dc-80e7-14b8fdd3e2f3)
- [Novartis Pharma AG](https://www.keypedia.com/companies/novartis-pharma-ag/7044f14d-b39e-4509-b663-31655a0e9d6e)